ouabain has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eichberg, J; Fox, DA; Garcia, CA; Ottlecz, A | 1 |
| Bensaoula, T; Ottlecz, A | 1 |
2 other study(ies) available for ouabain and Diabetic Retinopathy
| Article | Year |
|---|---|
Alterations in retinal Na+, K(+)-ATPase in diabetes: streptozotocin-induced and Zucker diabetic fatty rats.
Topics: Animals; Ca(2+) Mg(2+)-ATPase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Hyperglycemia; Isoenzymes; Male; Ouabain; Rats; Rats, Zucker; Retina; Sodium-Potassium-Exchanging ATPase; Streptozocin; Time Factors | 1993 |
Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Bacterial Agents; Blood Glucose; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Enzyme Inhibitors; Isoenzymes; Male; Ouabain; Peptidyl-Dipeptidase A; Random Allocation; Rats; Retina; Sodium-Potassium-Exchanging ATPase; Streptozocin | 1996 |